Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Protozoan Infections D011528 6 associated lipids
Tick Bites D064927 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Shinkai M and Rubin BK Macrolides and airway inflammation in children. 2005 Paediatr Respir Rev pmid:16153572
Gabrielli M et al. Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome. 2005 Am. Heart J. pmid:16084141
Sharma S and El-Refaey H Vaginal azithromycin and misoprostol before surgical abortion. 2005 Fertil. Steril. pmid:16084904
Dandekar PK et al. Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model. 2005 Int. J. Antimicrob. Agents pmid:15894464
Eschenauer G et al. Azithromycin-warfarin interaction: are we fishing with a red herring? 2005 Pharmacotherapy pmid:15977924
Desmond N et al. Acceptability of azithromycin for the control of trachoma in Northern Tanzania. 2005 Trans. R. Soc. Trop. Med. Hyg. pmid:15979657
Burton MJ et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. 2005 Apr 9-15 Lancet pmid:15823382
Frota LC et al. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. 2005 Apr-Jun Arq Gastroenterol pmid:16127567
Schmutz JL et al. [Azithromycin and Stevens-Johnson syndrome]. 2005 Aug-Sep Ann Dermatol Venereol pmid:16230934
Elitok B et al. Efficacy of azithromycin dihydrate in treatment of cryptosporidiosis in naturally infected dairy calves. 2005 Jul-Aug J. Vet. Intern. Med. pmid:16095179
Mellenius H et al. [Mycoplasma genitalium should be suspected in unspecific urethritis and cervicitis. A study from Vasterbotten confirms the high prevalence of the bacteria]. 2005 Nov 21-27 Lakartidningen pmid:16408391
Peate I Physiological and general health effects of chlamydia on men. 2005 Oct 27-Nov 9 Br J Nurs pmid:16301944
Simunić M et al. Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure. 2005 Sep-Oct Ann Saudi Med pmid:16270770
Gower EW et al. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment. 2006 Invest. Ophthalmol. Vis. Sci. pmid:17065486
Daenas C et al. Azithromycin has a direct relaxant effect on precontracted airway smooth muscle. 2006 Eur. J. Pharmacol. pmid:17070799
Xu S et al. Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17120738
Pedro-Botet ML et al. Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin. 2006 J Chemother pmid:17127236
Faucher P and Madelenat P [Induced abortion]. 2006 Rev Prat pmid:17139871
Thomsen MB et al. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block. 2006 Br. J. Pharmacol. pmid:17088870
Hunfeld KP and Brade V Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. 2006 Wien. Klin. Wochenschr. pmid:17160604
Escudero E et al. Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits. 2006 Res. Vet. Sci. pmid:16530237
Cuffini C et al. Isolation of Chlamydophila pneumoniae from atheromas of the carotid artery and their antibiotics susceptibility profile. 2006 Enferm. Infecc. Microbiol. Clin. pmid:16545314
Jarvinen KA et al. Pharmaceutical Benefits Scheme limitations on macrolides: implications for pertussis management. 2006 Med. J. Aust. pmid:16548844
Meamar AR et al. Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin. 2006 Parasitol. Res. pmid:16416289
Plana MT et al. Toxic catatonia secondary to azithromycin. 2006 J Clin Psychiatry pmid:16649839
Miedinger D [Dysuria and urethral discharge after travel abroad]. 2006 Praxis (Bern 1994) pmid:16640179
Nalca Y et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. 2006 Antimicrob. Agents Chemother. pmid:16641435
Asgrimsson V et al. Novel effects of azithromycin on tight junction proteins in human airway epithelia. 2006 Antimicrob. Agents Chemother. pmid:16641453
Madroñero AB et al. [Azithromycin-induced delirium in on old patient]. 2006 Med Clin (Barc) pmid:16595092
Lück PC and Steinert M [Pathogenesis, diagnosis and therapy of Legionella infections]. 2006 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz pmid:16596363
Barr BS Rhodococcus equi pneumonia in a foal. 2006 Vet. Clin. North Am. Equine Pract. pmid:16627120
Wilms EB et al. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. 2006 Ther Drug Monit pmid:16628134
Wareham DW and Bean DC In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. 2006 Ann. Clin. Microbiol. Antimicrob. pmid:16630352
Niederman MS et al. Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. 2006 Respir Med pmid:16531032
An N et al. [Severe liver damage caused by intravenous infusion of azithromycin in a case]. 2006 Zhonghua Er Ke Za Zhi pmid:16780660
Alou L et al. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia. 2006 J. Antimicrob. Chemother. pmid:16782744
Argani H et al. Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste. 2006 Exp Clin Transplant pmid:16827637
Thoms KM et al. [Two brothers with brown, reticulate hyperpigmentations. Papillomatosis confluens et reticularis (Gougerot-Carteaud): familial occurrence and response to azithromycin]. 2006 J Dtsch Dermatol Ges pmid:16827916
Bradshaw CS et al. Azithromycin failure in Mycoplasma genitalium urethritis. 2006 Emerging Infect. Dis. pmid:16836839
Clement A et al. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial. 2006 Thorax pmid:16809416
Verleden GM et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. 2006 Am. J. Respir. Crit. Care Med. pmid:16741151
Sultana N et al. Degradation studies of azithromycin and its spectrophotometric determination in pharmaceutical dosage forms. 2006 Pak J Pharm Sci pmid:16751118
Ivetić Tkalcević V et al. Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. 2006 Eur. J. Pharmacol. pmid:16698012
Giles DK et al. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. 2006 Microbes Infect. pmid:16698305
Pedro-Botet L and Yu VL Legionella: macrolides or quinolones? 2006 Clin. Microbiol. Infect. pmid:16669926
Mikamo H et al. [Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. 2006 Jpn J Antibiot pmid:16673581
Atasoy M et al. A case of early onset confluent and reticulated papillomatosis with an unusual localization. 2006 J. Dermatol. pmid:16674793
Zhang H et al. Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year. 2006 Br J Ophthalmol pmid:16687452
Moon JE et al. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. 2006 Antimicrob. Agents Chemother. pmid:16723556
Bogdanovich T et al. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. 2006 Antimicrob. Agents Chemother. pmid:16723565
Kosowska-Shick K et al. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. 2006 Antimicrob. Agents Chemother. pmid:16723567
Zhanel GG et al. Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. 2006 Antimicrob. Agents Chemother. pmid:16723591
Petrini B Mycobacterium abscessus: an emerging rapid-growing potential pathogen. 2006 APMIS pmid:16725007
Enders M et al. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany. 2006 Eur. J. Clin. Microbiol. Infect. Dis. pmid:16733613
Gaillac N et al. Legionella pneumophila pneumonia during pregnancy: a case report. 2006 J. Infect. pmid:16246423
Shinkai M et al. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16085674
Equi AC et al. Exploring the mechanisms of macrolides in cystic fibrosis. 2006 Respir Med pmid:16185859
Cofré Guerra J [Pertussis chemoprophylaxis: a sterile effort?]. 2006 Rev Chilena Infectol pmid:16462967
Sheeder J et al. Cervicitis: to treat or not to treat? The role of patient preferences and decision analysis. 2006 J Adolesc Health pmid:17116520
Young MK et al. Two years of enhanced surveillance of sexually-transmitted chlamydia in South East Queensland. 2006 Commun Dis Intell Q Rep pmid:17330388
Alagić-Smailbegović J et al. Azythromicin versus amoxicillin-clavulanate in the treatment of acute sinusitis in children. 2006 Bosn J Basic Med Sci pmid:17177656
Tsuji E et al. Evaluation of bitterness suppression of macrolide dry syrups by jellies. 2006 Chem. Pharm. Bull. pmid:16508183
Topic A et al. Azithromycin: 1.0 or 3.0 gram dose in the treatment of patients with asymptomatic urogenital chlamydial infections. 2006 J Chemother pmid:16572905
O'Farrell N et al. Periodic presumptive treatment for cervical infections in service women in 3 border provinces of Laos. 2006 Sex Transm Dis pmid:16645552
Hsueh PR et al. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. 2006 Clin. Microbiol. Infect. pmid:16451421
Caronzolo D et al. Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection. 2006 Antimicrob. Agents Chemother. pmid:17005805
Halling SM and Jensen AE Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications. 2006 BMC Microbiol. pmid:17014718
Rafiei R and Yaghoobi R Azithromycin versus tetracycline in the treatment of acne vulgaris. 2006 J Dermatolog Treat pmid:16971315
Atasoy M and AliaÄŸaoÄŸlu C Is confluent and reticulated papillomatosis without papillomatosis early or late stage of confluent and reticulated papillomatosis? 2006 J. Cutan. Pathol. pmid:16972956
Vladusić I et al. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review]. 2006 Acta Med Croatica pmid:16933840
Bergman M et al. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. 2006 Antimicrob. Agents Chemother. pmid:16940064
Rackstraw S et al. Can chlamydial conjunctivitis result from direct ejaculation into the eye? 2006 Int J STD AIDS pmid:16942659
Russo V et al. Azithromycin-induced QT prolongation in elderly patient. 2006 Acta Biomed pmid:16856707
Luxameechanporn T et al. The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. 2006 Int. J. Infect. Dis. pmid:16564192
Dan M et al. Pharyngeal Gonorrhea in female sex workers: Response to a single 2-g dose of azithromycin. 2006 Sex Transm Dis pmid:16572040
Lundbäck D et al. Molecular epidemiology of Neisseria gonorrhoeae- identification of the first presumed Swedish transmission chain of an azithromycin-resistant strain. 2006 APMIS pmid:16499664
Ishihama K et al. Azithromycin as prophylaxis for the prevention of postoperative infection in impacted mandibular third-molar surgery. 2006 J. Infect. Chemother. pmid:16506087
Tilelli JA et al. Life-threatening bradyarrhythmia after massive azithromycin overdose. 2006 Pharmacotherapy pmid:16506357
Kang MS et al. [Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication]. 2006 Korean J Gastroenterol pmid:16434866
Angel LF et al. Azithromycin in bronchiolitis obliterans: is the evidence strong enough? 2006 Am. J. Respir. Crit. Care Med. pmid:16467178
Phaff SJ et al. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. 2006 J. Antimicrob. Chemother. pmid:16469851
Coulter JB et al. Nontuberculous mycobacterial adenitis: effectiveness of chemotherapy following incomplete excision. 2006 Acta Paediatr. pmid:16449024
Bahrami G and Mohammadi B A new on-line, in-tube pre-column derivatization technique for high performance liquid chromatographic determination of azithromycin in human serum. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16310417
Wright HR et al. Trachoma and the need for a coordinated community-wide response: a case-based study. 2006 PLoS Med. pmid:16492074
Bogdanovich T et al. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. 2006 Antimicrob. Agents Chemother. pmid:16495248
Mazereeuw-Hautier J [Impetigo]. 2006 Ann Dermatol Venereol pmid:16508614
Mitchell SJ et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. 2006 Clin. Infect. Dis. pmid:16392078
Azithromycin extended-release (Zmax) for sinusitis and pneumonia. 2006 Obstet Gynecol pmid:16394059
Toltzis P et al. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. 2006 Pediatr. Infect. Dis. J. pmid:16395097
Ballard RC et al. Azithromycin versus penicillin for early syphilis. 2006 N. Engl. J. Med. pmid:16407519
Mousavi S et al. Azithromycin in one week quadruple therapy for H pylori eradication in Iran. 2006 World J. Gastroenterol. pmid:16874871
Merriam CV et al. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. 2006 Int. J. Antimicrob. Agents pmid:16875802
Horner P The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. 2006 Sex Transm Infect pmid:16877590
Cigana C et al. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. 2006 Biochem. Biophys. Res. Commun. pmid:17045242
Noedl H et al. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. 2006 Clin. Infect. Dis. pmid:17051490
Emerson PM et al. The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation. 2006 Bull. World Health Organ. pmid:16917648
Furuya R et al. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. 2006 J. Infect. Chemother. pmid:16944253
Fairgrieve WT et al. Concentrations of erythromycin and azithromycin in mature Chinook salmon Oncorhynchus tshawytscha after intraperitoneal injection, and in their progeny. 2006 Dis. Aquat. Org. pmid:16610588
Tungikar SL et al. Primary amebic meningoencephalitis. 2006 J Assoc Physicians India pmid:16944619
Legssyer R et al. Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. 2006 Respir. Res. pmid:17064416